Live Breaking News & Updates on Rezolute Inc

Stay updated with breaking news from Rezolute inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Rezolute Reports Second Quarter Fiscal 2024 Results and Provides Business Update

Rezolute Reports Second Quarter Fiscal 2024 Results and Provides Business Update
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Christen-baglaneas , Daron-evans , Stephanie-carrington , Nevan-charles-elam , Access-program , European-medicines-agency , Rezolute-inc , Securities-exchange , Regulatory-agency , Nasdaq , Reports-second-quarter-fiscal

Rezolute Reports Second Quarter Fiscal 2024 Results and Provides Business Update

13.02.2024 - Phase 3 clinical study of RZ358 underway in patients with congenital hyperinsulinism (cHI); topline results expected in mid-2025 Benefit shown in individual patient cases with RZ358 for tumor-associated hyperinsulinism (taHI) under Expanded Access . ....

Christen-baglaneas , Nevan-charles-elam , Daron-evans , Stephanie-carrington , Regulatory-agency , Nasdaq , European-medicines-agency , Securities-exchange , Rezolute-inc , Access-program , Chief-executive-officer

Why Aclarion Shares Are Trading Higher By Around 53%; Here Are 20 Stocks Moving Premarket - argenx (NASDAQ:ARGX), Aclarion (NASDAQ:ACON)

Shares of Aclarion, Inc. (NASDAQ: ACON) shares rose sharply in pre-market trading after the company was granted U.S. patent #11844601 for "MR SPECTROSCOPY SYSTEM FOR DIAGNOSING PAINFUL AND NON-PAINFUL INTERVERTEBRAL DISCS (Severe Low Back Pain)." ....

Robert-carey , Steelcase-inc , Nogin-inc , Technology-group-inc , Renewables-limited , Group-inc , Xilio-therapeutics-inc , Panbela-therapeutics-inc , Northann-corp , U-power-limited , Regional-health-properties-inc , Aeye-inc

Rezolute Initiates Phase 3 Clinical Study for RZ358 in Congenital Hyperinsulinism

REDWOOD CITY, Calif., Dec. 14, 2023 (GLOBE NEWSWIRE) Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company committed to developing novel, transformative therapies for serious metabolic and rare diseases, today ....

Stephanie-carrington , Nevan-charles-elam , Rezolute-inc , Nasdaq , Securities-exchange , European-medicines-agency , Chief-executive-officer , Securities-act , Securities-exchange-act , Private-securities-litigation-reform-act , Risk-factors , Annual-report